Royce & Associates LP Acquires 53,092 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Royce & Associates LP increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 28.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 237,416 shares of the technology company's stock after buying an additional 53,092 shares during the period. Royce & Associates LP owned 1.18% of Simulations Plus worth $7,602,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. nVerses Capital LLC raised its holdings in shares of Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after purchasing an additional 1,100 shares during the period. EntryPoint Capital LLC bought a new position in shares of Simulations Plus in the 1st quarter worth $57,000. Allspring Global Investments Holdings LLC bought a new stake in Simulations Plus during the 1st quarter valued at $70,000. US Bancorp DE raised its holdings in Simulations Plus by 37.0% during the third quarter. US Bancorp DE now owns 4,974 shares of the technology company's stock worth $159,000 after buying an additional 1,343 shares during the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Simulations Plus during the second quarter valued at about $206,000. Institutional investors own 78.08% of the company's stock.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total value of $625,200.00. Following the transaction, the director now directly owns 3,481,592 shares of the company's stock, valued at $108,834,565.92. The trade was a 0.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders sold 60,750 shares of company stock valued at $1,905,655. Insiders own 20.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on SLP. KeyCorp started coverage on Simulations Plus in a research note on Monday, July 29th. They set an "overweight" rating and a $47.00 price target for the company. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research note on Wednesday, November 6th. StockNews.com downgraded Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, November 4th. Stephens started coverage on Simulations Plus in a research note on Friday. They set an "overweight" rating and a $39.00 target price on the stock. Finally, BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $51.40.

Simulations Plus Stock Performance

Simulations Plus stock traded down $0.48 during mid-day trading on Monday, reaching $28.29. The company's stock had a trading volume of 176,355 shares, compared to its average volume of 134,811. The company has a market capitalization of $567.78 million, a P/E ratio of 59.23 and a beta of 0.71. Simulations Plus, Inc. has a 12-month low of $27.22 and a 12-month high of $51.22. The firm's fifty day moving average price is $31.19 and its two-hundred day moving average price is $38.83.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million for the quarter, compared to analysts' expectations of $19.73 million. During the same period in the prior year, the company posted $0.18 EPS. The business's revenue for the quarter was up 19.9% compared to the same quarter last year. On average, research analysts predict that Simulations Plus, Inc. will post 1.12 EPS for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.